Dr. Elías Campo is one of the most prominent researchers at IDIBAPS and Professor of Pathology at the University of Barcelona. He combines the positions of director of research at the Hospital Clínic of Barcelona and director of the Clínic Foundation with his work as head of the IDIBAPS research team Human and experimental functional oncomorphology. Investigations he led as co- director of the Spanish Consortium for the chronic lymphocytic leukemia Genome have provided valuable information on the genetics and treatment of this leukemia, the most common in Western countries. Today has been announced that the Catalan Foundation for Research and Innovation, with support from the Government of Catalonia, has recognized his work with the Premi Nacional de Recerca (Catalan National Award for Research), the highest award of Catalan science. The statement announcing the award highlights that “his research has identified cells that cause leukemia, discovered new molecular mechanisms involved in its development and improved its diagnosis.”
Posts Tagged ‘Elias Campo’
Dr. Elías Campo awarded with the the Premi Nacional de Recerca (Catalan National Award for Research)
Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas. The result of this work, published today in the prestigious U.S. journal Proceedings of the National Academy of Sciences (PNAS), presents the first comprehensive genomic analysis of this disease. “The study provides insight into causes and evolution of this complex neoplasm and has identified targets for new treatments“, says Dr. Silvia Beà, first author of the study.
Prof. Reiner Siebert is a Human Geneticist pioneering the genomic profiling and sequence analysis of B-cell lymphomas at the Institute of Human Genetics of the Christian-Albrechts-Universität zu Kiel (Germany). He was invited by Dr. Elías Campo, head of the Human and experimental functional oncomorphology IDIBAPS team and Director of Research at the Hospital Clínic of Barcelona, to offer an IDIBAPS Seminar held on May 6th. Dr. Iñaki Martín – Subero, investigator from Dr. Campo’s team and a former student at Prof. Siebert’s laboratory, introduced this crowded seminar.
Spanish Consortium for the Study of the Genome of the Chronic Lymphatic Leukemia, co-led by Dr. Elías Campo, links for the first time cancer with errors in the protection of chromosomes
A research published by Nature Genetics explores a new mechanism that may contribute to the development of diverse tumors, including chronic lymphatic leukemia, a form of cancer that affects thousands of new patients each year in Spain. The researchers have detected for the first time in a human cancer the mutation of an essential gene for the protection of the telomeres, situated on the edges of the chromosomes. The research, directed by Carlos López-Otín, of the University Institute of Oncology of the University of Oviedo, Elías Campo, of the Clínic Hospital/University of Barcelona, and María Blasco, director of the National Center of Oncological Research (CNIO), breaks new ground for the Spanish Consortium for the Study of the Genome of the Chronic Lymphatic Leukemia.
IDIBAPS investigators describe the genetic profile of an uncommon subtype of mantle cell lymphoma improving its proper diagnosis
Mantle cell lymphoma (MCL)is a subtype of B-cell lymphoma that comprises about 6-7% of all non-Hodgkin’s lymphoma cases. The main biomarker of this usually aggressive lymphoma is an alteration in Cyclin D1 expression. An article led by IDIBAPS investigators, and published in Blood(1), characterizes a new subtype of MCLs in which Cyclin D1 expression is not altered and offers clues to close different controversies about the genetics of the disease. Dr. Itziar Salaverria is the first author of the article, while the Miguel Servet investigator Dr. Sílvia Beà is the last one, both from the Human and experimental functional oncomorphology IDIBAPS team led by Dr. Elías Campo. Due to its significance, the article was highlighted by its editors as one of the “hottest” manuscripts to the media and selected for a comment (2) in the last issue of the Blood magazine.
2012 is ending, a difficult year also for science due to the crisis affecting much of the world. Despite this, it’s not all are bad news. The spanish researchers continue making relevant contributions to the international scientific scene. The website Materia made a top five of the Spanish scientific initiatives of the past year. In this ranking, there are three studies involving professionals from the Hospital Clínic and the IDIBAPS.